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General Considerations. 
 
All reactions were performed at room temperature in an N2-filled M. Braun Glovebox or by using 
standard Schlenk techniques unless otherwise specified. Glassware was oven dried at 140° C for 
at least 2h prior to use, and allowed to cool under vacuum. All reagents were used as received 
unless otherwise stated. Iodosobenzene (PhIO), 2,6-difluorophenylpyrazole, 6-methoxy-2-
fluoroacetophenone, and [LFe3(PhPz3)OFe][OTf]2 (1) were synthesized according to published 
procedures.1-4 Caution! Iodosobenzene is potentially explosive and should be used only in small 
quantities. Phenyl-1H-pyrazole, 3-(2-hydroxyphenyl)-1H-pyrazole, 6-methoxy-2-
fluorobenzaldehyde, 2,6-difluoroacetophenone, Na(N(SiMe3)2), and AgOTf, were purchased 
from Sigma Aldrich, Oakwood Chemicals and Strem Chemicals. All commercially available 
pyrazoles were sublimed before use. Anhydrous tetrahydrofuran (THF) was purchased from 
Aldrich in 18 L Pure-PacTM containers. Anhydrous CH2Cl2, diethyl ether, hexane and THF were 
purified by sparging with nitrogen for 15 minutes and then passing under nitrogen pressure 
through a column of activated A2 alumina. Anhydrous 1,2-dimethoxyethane (DME) was dried 
over sodium/benzophenone and vacuum-transferred onto molecular sieves. The 1H, and 13C{1H} 
NMR spectra were recorded at 400.13, and 100.62 MHz on a Bruker AscendTM 400 MHz 
spectrometer equipped with prodigy cryoprobe, or at 300.13, 282.36 (19F), and 75.47 MHz, 
respectively, on a Varian 300 MHz spectrometer. All chemical shifts (δ) are reported in ppm, and 
coupling constants (J) are in Hz. The 1H and 13C{1H} NMR spectra were referenced using 
residual solvent peaks in the deuterated solvent. The 19F chemical shifts are reported relative to 
the internal lock signal. Deuterated solvents (CD2Cl2 and CD3CN) were purchased from 
Cambridge Isotope Laboratories, dried over calcium hydride, degassed by three freeze-pump-
thaw cycles and vacuum-transferred prior to use. The UV-vis spectra were recorded on a Varian 
Cary Bio 50 spectrophotometer. Fast atom bombardment-mass spectrometry (FAB-MS) analysis 
was performed with a JEOL JMS-600H high resolution mass spectrometer. Gas chromatography-
mass spectrometry (GC-MS) analysis was performed upon filtering the sample through a plug of 
alumina gel. Elemental analyses were performed by Midwest Microlab, IN, Robertson Microlit 
Laboratories, NJ, or at Caltech. 
 
Physical Methods. 
 
Mössbauer measurements. Zero-field 57Fe Mössbauer spectra were recorded at 80 K in the 
constant acceleration mode on a spectrometer from See Co (Edina, MN) equipped with an SVT-
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400 cryostat (Janis, Wilmington, WA). The quoted isomer shifts are relative to the centroid of the 
spectrum of a α-Fe foil at room temperature. Samples were prepared by grinding polycrystalline 
material (20 mg) into a fine powder and pressed into a homogeneous pellet with boron nitride in a 
cup fitted with a screw cap. The data were fitted to Lorentzian lineshapes using the program 
WMOSS (www.wmoss.org). For a detailed fitting procedure see page S37. 
 
X-ray crystallography. For compounds 2, 3, 5, 7–8, low-temperature (100 K) diffraction data 
(φ-and ω-scans) were collected on a Bruker AXS D8 VENTURE KAPPA diffractometer coupled 
to a PHOTON 100 CMOS detector with Mo Kα radiation (λ = 0.71073 Å) or with Cu Kα (λ = 
1.54178 Å). For compound 5, low-temperature (100 K) diffraction data (φ-and ω-scans) were 
collected on a Bruker AXS KAPPA APEX II diffractometer coupled to an APEX II CCD 
detector with graphite monochromated Mo Kα radiation (λ = 0.71073 Å). All diffractometer 
manipulations, including data collection, integration, and scaling were carried out using the 
Bruker APEXII software.5 Absorption corrections were applied using SADABS.6 Structures were 
solved by direct methods using SHELXS7 and refined against F2 on all data by full-matrix least 
squares with SHELXL-2014 using established refinement techniques. All non-hydrogen atoms 
were refined anisotropically. All hydrogen atoms were included into the model at geometrically 
calculated positions and refined using a riding model. The isotropic displacement parameters of 
all hydrogen atoms were fixed to 1.2 times the U value of the atoms they are linked to (1.5 times 
for methyl groups). All disordered atoms were refined with the help of similarity restraints on the 
1,2- and 1,3-distances and displacement parameters as well as enhanced rigid bond restraints for 
anisotropic displacement parameters. Due to the size of compounds (2, 3, 5, and 7–8), most 
crystals included solvent accessible voids, which tended to contain disordered solvent. In most 
cases, this disorder could be modeled satisfactorily Furthermore, the long-range order of these 
crystals and amount of high angle data was in some cases not ideal, due to desolvation of the 
crystals and/or solvent disorder. These disordered solvent molecules were largely responsible for 
the alerts generated by the checkCIF protocol. Although several attempts were made to crystallize 
compound 8, we were not able to obtain a crystal structure suitable for analysis of bond distances 
and angles. The structure contained within the manuscript and supporting information is only for 
structural identification only. 
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Synthetic Procedures 
 
1-(2-fluoro-6-methoxyphenyl)ethan-1-ol. In the glovebox, to a thawing solution of 2-fluoro-6-
methoxybenzaldehyde (2.5 g; 18.1 mmol) in diethyl ether (25 mL) was added MeMgBr (3.0 M in 
diethyl ether; 12 mL, 36.0 mmol). The resulting grey suspension was stirred for ca. 24 h. Next, 
the suspension was cooled, outside of the glovebox, to 0° C and carefully quenched with 3.0 M 
hydrochloric acid. Ethyl acetate (25 mL) was added and the aqueous phase extracted with ethyl 
acetate (3 × 25 mL). The organic fractions were pooled together, washed with brine, and dried 
over MgSO4. The volatiles were removed under reduced pressure to yield 1-(2-fluoro-6-
methoxyphenyl)ethan-1-ol as a colorless oil (2.55 g; 83%). 1H NMR (400 MHz, CDCl3) δ 7.19 
(td, J = 8.3, 6.5 Hz, 1H; p-ArH), 6.70 (td, J = 8.5, 1.2 Hz, 2H; m-ArH), 5.25 (dq, J = 10.9, 6.7 Hz, 
1H; CHCH3), 3.90 (s, 3H; OCH3), 3.37 (dd, J = 10.9, 1.2 Hz, 1H; OH), 1.58 (d, J = 6.7 Hz, 3H; 
CHCH3). 13C NMR (101 MHz, CDCl3) δ 160.14 (d, J = 243.9 Hz; C-F), 158.30 (d, J = 8.0 Hz; 
COMe), 128.50 (d, J = 11.0 Hz; p-ArC), 120.33 (d, J = 16.5 Hz; i-ArC), 108.60 (d, J = 23.6 Hz; 
m-ArC), 106.77 (d, J = 2.9 Hz; m-ArC), 63.47 (d, J = 5.8 Hz; CH), 55.89 (s; OCH3), 23.69 (s; 
CH3). 19F NMR (282 MHz, CDCl3) δ -118.15 (dd, J = 9.9, 6.6 Hz). 
 
2-fluoro-6-methoxyacetophenone. To a solution of 1-(2-fluoro-6-methoxyphenyl)ethan-1-ol 
(2.55 g; 15 mmol) in DMF (30 mL) was added pyridinium dichromate (8.80 g; 23.5 mmol). The 
solution was stirred for ca. 24 h, where after H2O (75 mL) was added. The resulting mixture was 
extracted with ethyl acetate (3 × 50 mL). The organic fractions were pooled together, washed 
with brine, and dried over MgSO4. The volatiles were removed under reduced pressure to yield a 
crude yellow oil. The crude oil was purified by column chromatography (silica; 10:90 (v/v) ethyl 
acetate/hexane) to yield 2-fluoro-6-methoxyacetophenone as a colorless oil. Yield. 2.17 g (86%). 
1H NMR (400 MHz, CDCl3) δ 7.33 (td, J = 8.4, 6.6 Hz, 1H; p-ArH), 6.77 – 6.69 (m, 2H; m-ArH), 
3.87 (s, 3H; OCH3), 2.56 (d, J = 1.2 Hz, 3H; CCH3). 13C NMR (101 MHz, CDCl3) δ 198.85 (s; 
CO), 159.65 (d, J = 249.0 Hz; C-F), 157.62 (d, J = 7.7 Hz; COMe), 131.52 (d, J = 10.6 Hz; p-
ArC), 119.39 (d, J = 19.0 Hz; i-ArC), 108.39 (d, J = 22.3 Hz; m-ArC), 106.87 (d, J = 3.0 Hz; m-
ArC), 56.16 (s; OCH3), 32.43 (d, J = 1.4 Hz; CCH3). 19F NMR (282 MHz, CDCl3) δ -115.63 – -
115.72 (m). 
 
3-(2-fluoro-6-methoxyphenyl)-1H-pyrazole. Under N2, a Schlenk-tube was charged with 2-
fluoro-6-methoxyacetophenone (2.17 g; 12.8 mmol) and N,N-dimethylformamide 
dimethylacetal (1.79 g; 15.0 mmol). The tube was sealed and heated at 110° C for ca. 16 h. 
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Next, the volatiles were removed under reduced pressure to yield an orange oil (1-(2-fluoro-6-
methoxyphenyl)-3-(dimethylamino)-prop-2-en-1-one). The crude oil was used without further 
purification and dissolved in ethanol (20.0 mL). To the solution was added hydrazine 
monohydrate (1.0 mL; 20.6 mmol) and acetic acid (1.1 mL; 19.1 mmol) at 0° C. The mixture 
was stirred for 3 h. at 70° C, during which the color changed from orange to yellow.  Hereafter, 
the ethanol was removed under reduced pressure and the remaining solid was dissolved in ethyl 
acetate (20 mL). To the solution was added sat. sodium bicarbonate (10 mL) and the aqueous 
phase was extracted with ethyl acetate (3 × 25 mL). The organic fractions were pooled 
together, washed with brine, and dried over MgSO4. The volatiles were removed under reduced 
pressure and the crude solid was purified by flash column chromatography (silica; 40:60 (v/v) 
hexane/ethyl acetate), to yield 3-(2-fluoro-6-methoxyphenyl)-1H-pyrazole as a light yellow 
solid (2.21 g; 89%). 1H NMR (400 MHz, CDCl3) δ 11.56 (br, 1H; NH), 7.69 (d, J = 1.9 Hz, 
1H; CHCHNH), 7.27 (td, J = 8.4, 6.8 Hz, 1H; p-ArH), 6.91 – 6.82 (m, 3H; m-ArH and 
CHCHNH), 4.02 (s, 3H; OCH3). 13C NMR (101 MHz, CDCl3) δ 160.26 (d, J = 249.9 Hz; C-F), 
157.17 (d, J = 6.9 Hz; COMe), 139.54 (s; CHCHNH), 134.16 (s; i-ArC), 128.95 (d, J = 11.5 
Hz; p-ArC), 109.29 (d, J = 23.8 Hz; m-ArC), 107.11 (d, J = 3.0 Hz; CHCHNH), 106.91 (d, J = 
12.9 Hz; m-ArC), 56.43 (s; OCH3). 19F NMR (282 MHz, CDCl3) δ -109.75. 
 
3-(2-fluoro-6-hydroxyphenyl)-1H-pyrazole. 3-(2-fluoro-6-methoxyphenyl)-1H-pyrazole (1.6 
g; 8.3 mmol) was dissolved in concentrated HBr (48%; 25 mL) and refluxed for ca. 24 h. The 
dark brown solution was cooled to 0° C and the pH adjusted to 7. The suspension was extracted 
with ethyl acetate (3 × 50 mL). The organic fractions were pooled together, washed with brine, 
and dried over MgSO4. The volatiles were removed under reduced pressure and the crude solid 
was purified by flash column chromatography (silica; 40:60 (v/v) hexane/ethyl acetate). The 
resulting solid was subsequently sublimed under vacuum to yield 3-(2-fluoro-6-
hydroxyphenyl)-1H-pyrazole as a white solid (1.1 g; 75%). 1H NMR (400 MHz, CD3CN) δ 
11.60 (s, 2H; NH and OH), 7.82 (d, J = 2.5 Hz, 1H; CHCHNH), 7.21 (td, J = 8.3, 6.5 Hz, 1H; 
p-ArH), 6.88 (dd, J = 5.1, 2.6 Hz, 1H; CHCHNH), 6.82 (dt, J = 8.3, 1.1 Hz, 1H; m-ArH), 6.74 
(ddd, J = 11.6, 8.2, 1.1 Hz, 1H; m-ArH). 13C NMR (101 MHz, CD3CN) δ 160.88 (d, J = 246.9 
Hz; C-F), 157.77 (d, J = 6.3 Hz; COH), 146.16 (s; i-ArC), 129.65 (d, J = 3.5 Hz; CHCHNH), 
129.00 (d, J = 11.7 Hz; p-ArC), 112.55 (d, J = 2.9 Hz; m-ArC), 106.04 (d, J = 23.0 Hz; m-
ArC), 106.02 (s; CCHCHNH), 105.30 (d, J = 15.0 Hz; CCHCHNH). 19F NMR (282 MHz, 
CD3CN) δ -115.43 (dt, J = 11.6, 5.9 Hz). MS (m/z): calcd, 179.0621 [M+H]+ ; found, 179.0592 
(FAB+ , [M+H]+ ). 
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2-(1H-pyrazol-3-yl)-3-fluorophenolate (NaOFArPzH). In the glovebox, to a solution of 3-(2-
fluoro-6-hydroxyphenyl)-1H-pyrazole (1.1 g.; 6.2 mmol) in THF (10 mL) was added a solution of 
sodium bis(trimethylsilyl)amide (NaHMDS; 1.3 g; 7.0 mmol) in THF (2 mL). The homogenous 
solution was stirred for 2 h. where after solvent was removed under reduced pressure to yield a 
white solid. The solid was suspended in hexane (10 mL), collected on a medium porosity frit, 
washed with hexane (3 × 10.0 mL), and dried under reduced pressure to yield of sodium 2-(1H-
pyrazol-3-yl)-3-fluorophenolate as an off-white powder. Yield 1.1 g (88%). 1H NMR (400 MHz, 
CD3CN) δ 13.98 (s, 1H, NH), 7.44 (d, J = 1.8 Hz, 1H, CHCHNH), 6.80 (q, J = 8.0 Hz, 1H, p-
CH), 6.44 (dd, J = 5.5, 1.8 Hz, 1H, m-CH), 6.35 (dd, J = 8.4, 1.2 Hz, 1H, m-CH), 6.03 (ddd, J = 
11.4, 8.0, 1.2 Hz, 1H, CHCHNH). 13C NMR (101 MHz, CD3CN) δ 171.10 (d, J = 6.7 Hz, C-OH), 
161.63 (d, J = 244.0 Hz, C-F), 141.09 (s, i-ArC), 137.90 (s, CHCHNH), 127.01 (d, J = 13.8 Hz, 
p-ArC), 117.19 (d, J = 2.0 Hz; m-ArC), 106.47 (CCHCHNH), 102.23 (d, J = 12.3 Hz, (m-ArC), 
96.64 (d, J = 23.3 Hz, CHCHNH). 19F NMR (282 MHz, CD3CN) δ -115.73 (m). 
 
3-(2,6-difluorophenyl)-1H-pyrazole. Under N2, a Schlenk-tube was charged with 2,6-
difluoroacetophenone (2.60 mL; 20.0 mmol) and N,N-dimethylformamide dimethylacetal (2.65 
mL; 20.0 mmol). The tube was sealed and heated at 110° C for ca. 16 h. Next, the volatiles 
were removed under reduced pressure to yield an orange oil (1-(2,6-difluorophenyl)-3-
(dimethylamino)-prop-2-en-1-one). The crude oil was used without further purification and 
dissolved in ethanol (15 mL). To the solution was added hydrazine monohydrate (1.1 mL; 22.7 
mmol) and acetic acid (1.3 mL; 22.8 mmol). The mixture was stirred for 3 h. at 50° C, during 
which the color changed from orange to yellow.  Hereafter, the ethanol was removed under 
reduced pressure and the remaining oil was dissolved in ethyl acetate (10 mL). To the solution 
was added sat. sodium bicarbonate (25 mL) and the aqueous phase was extracted with ethyl 
acetate (3 × 25 mL). The organic fractions were pooled together, washed with brine, and dried 
over MgSO4. The volatiles were removed under reduced pressure and the crude solid was 
purified by flash column chromatography (silica; 40:60 (v/v) hexane/ethyl acetate). The 
resulting solid was subsequently sublimed under vacuum to yield 3-(2,6-difluorophenyl)-1H-
pyrazole as a light yellow solid (2.70 g; 75%). 1H NMR (400 MHz, CD3CN) δ 11.49 (s, 1H; 
NH), 7.73 (d, J = 2.2 Hz, 1H; CHCHNH), 7.41 (tt, J = 8.2, 6.3 Hz, 1H; p-ArH), 7.17 – 7.03 (m, 
2H; m-ArH), 6.67 (m, J = 2.0 Hz, 1H; CHCHNH). 13C NMR (101 MHz, CD3CN) δ 160.09 (dd, 
J = 249.1, 7.3 Hz; C-F), 132.75 (s; i-ArC) 129.75 (t, J = 10.7 Hz; p-ArC), 113.92 – 109.90 (m; 
m-ArC), 110.11 (s; CCHCHNH), 106.84 (t, J = 4.0 Hz; CCHCHN). 19F NMR (282 MHz, 
CD3CN) δ -113.39. MS (m/z): calcd, 181.0577 [M+H]+ ; found, 181.0587 (FAB+ , [M+H]+ ). 
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Sodium 3-(2,6-difluorophenyl)pyrazolate (NaF2ArPz). In the glovebox, to a solution of 3-(2,6-
difluorophenyl)-1H-pyrazole (2.70 g.; 15.0 mmol) in THF (20 mL) was added a solution of 
sodium bis(trimethylsilyl)amide (3.00 g; 18.0 mmol) in THF (5 mL). The color darkens to light 
yellow and the homogenous solution was stirred for 2 h. The solvent was removed under reduced 
pressure to yield a yellow foam. Addition of hexane (10.0 mL) resulted in the formation of a 
white precipitate, which was collected on a medium porosity frit. The solid was washed with 
hexane (3 × 20.0 mL) and dried under reduced pressure to yield of sodium 3-(2,6-
difluorophenyl)-pyrazolate (2.90 g; 95%) as an off-white powder. 1H NMR (400 MHz, CD3CN) δ 
7.53 (d, J = 1.6 Hz, 1H, CHCHN), 7.21 – 7.09 (m, 1H, p-ArH), 7.03 – 6.90 (m, 2H, m-ArH), 6.42 
(td, J = 2.6, 1.6 Hz, 1H, CHCHN). 13C NMR (101 MHz, CD3CN) δ 159.94 (dd, J = 244.7, 8.9 Hz, 
C-F), 138,92 (s, CCHCHN), 138.88 (t, J = 2.8, 1.9 Hz, CHCHN), 125.90 (t, J = 11.0 Hz, p-ArC), 
115.08 (t, J = 17.3 Hz, i-ArC), 113.68 – 109.65 (m, m-ArC), 104.44 (t, J = 4.1 Hz, CHCHN). 19F 
NMR (282 MHz, CD3CN) δ -114.69 – -114.85 (m). 
 
2-(1H-pyrazol-3-yl)phenolate (NaOArPzH). In the glovebox, to a solution of 3-(2-
hydroxyphenyl)-1H-pyrazole (480 mg.; 3.0 mmol) in THF (10 mL) was added a solution of 
sodium bis(trimethylsilyl)amide (550 mg; 3.0 mmol) in THF (2 mL). The homogenous solution 
was stirred for 2 h. where after solvent was removed under reduced pressure to yield a white 
solid. The solid was suspended in hexane (10 mL), collected on a medium porosity frit, washed 
with hexane (3 × 10.0 mL), and dried under reduced pressure to yield of sodium 2-(1H-pyrazol-3-
yl)phenolate (475 mg; 87%) as an off-white powder. 1H NMR (400 MHz, CD3CN) δ 7.42 (dd, J = 
7.3, 1.9 Hz, 2H; o-ArH and CHCHNH), 6.93 (ddd, J = 8.4, 6.9, 1.9 Hz, 1H; p-ArH), 6.61 (dt, J = 
8.3, 1.0 Hz, 1H; m-ArH), 6.42 (dd, J = 2.0, 0.7 Hz, 1H; CHCHNH), 6.36 – 6.27 (m, 1H; m-ArH). 
13C NMR (101 MHz, CD3CN) δ 168.75 (C-OH), 146.74 (i-ArC), 137.40 (CCHCHNH), 128.32 
(p-ArC), 126.24 (o-ArC), 121.59 (m-ArC), 117.12 (CCHCHNH), 110.56 (m-ArC), 97.62 
(CCHCHNH). 
  
[LFe3(PhPz)2(OArPz)OFe][OTf]1 (3); Method A. In the glovebox, to a solution of 
[LFe3(PhPz)3OFe][OTf]2 (184.6 mg; 0.10 mmol) in CH2Cl2 (8.0 mL) was added a suspension 2-
(1H-pyrazol-3-yl)-3-phenolate (NaOArPzH; 20.5 mg; 0.11 mmol) in CH2Cl2 (1.0 mL). The 
solution was stirred for ca. 48 h., during which the color changed from brown to red/brown. The 
solution was filtered over a bed of Celite (0.5 cm) in a glass pipette and the solvent removed 
under reduced pressure. The red/brown solid (173 mg) was crystallized from CH2Cl2/Et2O to 
yield [LFe3(PhPz)2(OPhPz)OFe][OTf]1 as a red/brown solid. Yield 129 mg (78%). 1H NMR (300 
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MHz, CD2Cl2) δ 122.0 (br), 120.4 (br), 117.6 (br), 86.4 (br), 79.6 (br), 74.5 (s), 72.8 (s), 72.0 (s), 
67.1 (s), 61.5 (s), 55.5 (s), 54.2 (s), 51.0 (br), 48.5 (s), 46.9 (s), 45.3 (s), 42.7 (s), 37.8 (s), 35.8 
(s), 30.3 (s), 27.3 (s), 26.6 (s), 26.2 (s), 25.3 (s), -2.9 (br), -4.9 (s), -11.0 (br), -15.0 (s), -39.9 (br). 
19F NMR (282 MHz, CD2Cl2) δ -78.8. UV-Vis (CH2Cl2) [ε (M-1 cm-1)]: 253 nm (8.41 × 104), 309 
nm (1.84 × 103), 498 (6.15 × 103). Anal. calcd. (%) for C85H59F3Fe4N12O8S1: C 60.45, H 3.52, N 
9.95; found: C 59.76, H 3.54, N 9.53. 
 
[LFe3(PhPz)2(OArPz)OFe][OTf]1 (3); Method B. In the glovebox, to a solution of 
[LFe3(PhPz)2(OArPz)OFe][OTf]2 (36.9 mg, 0.02 mmol; from method A) in CH2Cl2 (3 mL), was 
added a solution of cobaltocene (CoCp2, 3.8 mg, 0.02 mmol) in CH2Cl2 (1 mL). Upon addition 
the reaction mixture changed color from green/black to red/brown immediately. The reaction 
mixture was stirred for 2 h, and the volatiles were removed under reduced pressure. NMR 
analysis of the crude reaction mixture revealed > 90% conversion to 
[LFe3(PhPz)2(OPhPz)OFe][OTf]1. A small paramagnetic impurity is present and is of unknown 
identity. 1H NMR is identical to that of [LFe3(PhPz)2(OArPz)OFe][OTf]1 (Figure S18). 	  
[LFe3(PhPz)2(OArPz)OFe][OTf]2 (2); Method A. In the glovebox, to a solution of 
[LFe3(PhPz)3OFe][OTf]2 (367.0 mg; 0.2 mmol) in CH2Cl2 (15 mL), was added a suspension of 
iodosobenzene (PhIO; 50.0 mg; 0.23 mmol) as a solid.  The resulting suspension was stirred for 
ca. 16 h. where upon the mixture became a homogenous green/black solution. The volatiles were 
removed under reduced pressure to yield a crude black solid (342.2 mg), which was mainly 
[LFe3(PhPz)2(OArPz)OFe][OTf]2 as judged by 1H NMR. The crude solid was crystallized from 
MeCN/Et2O to give [LFe3(PhPz)2(OArPz)OFe][OTf]2 as black crystals. Yield 190 mg (52%). 1H 
NMR (300 MHz, CD2Cl2) δ 146.2 (br), 140.0 (br), 119.9 (br), 111.5 (br), 105.5 (br), 88.6 (s), 81.8 
(s), 80.6 (s), 75.6 (s), 72.4 (s), 68.6 (s), 65.0 (s), 64.6 (s), 63.9 (s), 54.6 (s), 49.7 (s), 47.7 (s), 38.8 
(s), 30.4 (s), 30.0 (s), 26.6 (s), 18.4 (s), 16.3 (s), 14.7 (s), 12.0 (s), 10.8 (s), -4.8 (br), -6.7 (br), -9.9 
(s), -19.3 (s), -25.5 (br). 19F NMR (282 MHz, CD2Cl2) δ -78.1. UV-Vis (CH2Cl2) [ε (M-1 cm-1)]: 
244 nm (9.37 × 104), 366 nm (8.99 × 103), 462 nm (6.53 × 103). Anal. calcd. (%) for 
C86H59F6Fe4N12O11S2: C 56.20, H 3.24, N 9.15; found: C 55.83, H 3.12, N 8.78. 
 
[LFe3(PhPz)2(OArPz)OFe][OTf]2 (2); Method B. In the glovebox, to a solution of 
[LFe3(PhPz)3OFe][OTf]3 (200.6 mg; 0.10 mmol) in CH2Cl2 (8.0 mL) was added a suspension 2-
(1H-pyrazol-3-yl)-3-phenolate (NaOArPzH; 20.4 mg; 0.11 mmol) in CH2Cl2 (1.0 mL). The 
solution was stirred for ca. 48 h., during which the color changed from brown to green/black. The 
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solution was filtered over a bed of Celite (0.5 cm) in a glass pipette and the solvent removed 
under reduced pressure. The black solid (181 mg) was crystallized from MeCN/Et2O to give 
[LFe3(PhPz)2(OArPz)OFe][OTf]2 as a black crystals. Yield 91 mg (49%). The 1H NMR was 
identical to that of Method A (Figure S21). Note that a small impurity ([LFe3(PhPz)3OFe][OTf]2) 
remained present, even upon repeated recrystallization. 
 
[LFe3(PhPz)2(OArPz)OFe][OTf]2 (2); Method C. In the glovebox, to a rapidly stirred solution 
of [LFe3(PhPz)2(OArPz)OFe][OTf]1 (23 mg, 0.013 mmol) in CH2Cl2 (2.0 mL) was added silver 
triflate (AgOTf; 3.9 mg, 0.015 mmol) as a suspension in CH2Cl2 (1.0 mL). The solution was 
stirred for 2 h., during which the color changed from red/brown to green/black. The solution was 
filtered over a bed of Celite (0.5 cm) in a glass pipette, and solvent was removed under reduced 
pressure to yield [LFe3(PhPz)2(OArPz)OFe][OTf]2 as a black solid. Yield 19 mg (79%). The 1H 
NMR was identical to that of Method A (Figure S21). Note, the paramagnetic peaks between 25-
30 ppm are fluxional, and deviate slightly from method A. 
 
[LFe3(PhPz)2(OArPz)OFe][OTf]2 (2); Method D. In the glovebox, to a stirring solution of 
[LFe3(PhPz)3OFe][OTf]2 (90.9 mg, 0.05 mmol) in DCM (2.0 mL) was added a solution of 
tetrabutylammoniun periodate (nBu4NIO4; 22.1 mg, 0.05 mmol) in DCM (1.0 mL). The yellow 
brown solution turned green/black immediately and after 30 minutes the solvents were removed 
under reduced pressure to yield a crude black solid (95.2 mg). The 1H NMR was identical to that 
of Method C (Figure S22).  
 
[LFe3(F2ArPz)3OFe][OTf]1 (4). In the glovebox, a suspension of LFe3(OAc)(OTf)2 (4143 mg, 
3.0 mmol) in THF (125 mL) is frozen in the cold well. To the thawing suspension is added 
sodium 2,6-difluorophenylpyrazolate (NaF2ArPz; 2011 mg, 10.0 mmol) in THF (10 mL). The 
color changed immediately to orange and the suspension became homogeneous during the course 
of 1 hour. The solution was stirred for a total of 2 h, and a yellow/brown suspension was formed. 
Next, iodosobenzene (PhIO, 660 mg, 3.0 mmol) was added as a solid, and the suspension turned 
dark brown and homogeneous. After 1 h, iron(II) trifluoromethane sulfonate (Fe(OTf)2; 2192, 6.0 
mmol) was added, and the solution was stirred for ca. 16 h. Hereafter, the volatiles were removed 
under reduced pressure, and the remaining brown solid was redissolved in CH2Cl2 (125 mL). To 
the solution was added cobaltocene (CoCp2; 1200 mg; 6.0 mmol) and stirred for another 2 h, 
during which the color changed to red/brown. The volatiles were removed under reduced pressure 
and the remaining solid was washed with ether (20 mL), toluene (20 mL), and thoroughly with 
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dimethoxyethane (DME; 150 mL) on a medium porosity glass frit. The remaining red solid was 
collected and dried under vacuum to yield [LFe3(F2ArPz)3OFe][OTf]1 as a red solid. Yield 1960 
mg (37%). 1H NMR (300 MHz, CD2Cl2) δ 97.2 (br), 60.2 (s), 56.5 (s), 36.4 (s), 34.3 (s), 33.8 (s), 
29.3 (br), 24.3 (s), 15.5 (s), 13.4 (s), 13.1 (s), 9.5 (s), -3.6 (br), -8.0 (br). 19F NMR (282 MHz, 
CD2Cl2) δ -78.8. UV-Vis (CH2Cl2) [ε (M-1 cm-1)]: 252 nm (9.14 × 104), 350 nm (5.03 × 103), 507 
nm (3.3 × 103). Anal. calcd. (%) for C85H54F9Fe4N12O7S1: C 57.30, H 3.05, N 9.43; found: C 
57.44, H 2.99, N 9.36. 
 
[LFe3(F2ArPz)3OFe][OTf]2 (5). In the glovebox, to a rapidly stirred solution of 
[LFe3(F2ArPz)3OFe][OTf]1 (1960 mg, 1.1 mmol) in CH2Cl2 (50 mL) was added silver triflate 
(AgOTf; 312 mg, 1.1 mmol) as a solid. The solution was stirred for 2 h., during which the color 
changed from red/purple to brown. The solution was filtered over a bed of Celite (0.5 cm) on a 
medium porosity glass frit, and solvent was removed under reduced pressure to yield 
[LFe3(F2ArPz)3OFe][OTf]2 as a brown solid. Yield 1496 mg (70%). 1H NMR (300 MHz, CD2Cl2) 
δ 116.6 (br), 70.5 (s), 67.6 (s), 55.9 (br), 49.0 (s), 44.3 (s), 43.7 (s), 15.6 (s), 14.4 (s), 14.2 (s), 
12.8 (s), 1.7 (br), -3.2 (br). 19F NMR (282 MHz, CD2Cl2) δ -77.5. UV-Vis (CH2Cl2) [ε (M-1 cm-
1)]: 244 nm (9.28 × 104), 419 nm (6.18 × 103). Anal. calcd. (%) for C86H54F12Fe4N12O10S2: C 
53.49, H 2.82, N 8.70; found: C 52.71, H 2.66, N 8.66. 
 
Reaction of Iodosylbenzene (PhIO) and [LFe3(F2ArPz)3OFe][OTf]2. In the glovebox, to a 
solution of [LFe3(F2ArPz)3OFe(F)][OTf]2 (20.0 mg; 0.01 mmol) in CH2Cl2 (2.0 mL) was added a 
suspension of iodosobenzene (PhIO; 2.2 mg; 0.01 mmol) in CH2Cl2 (1.0 mL). The mixture was 
stirred for ca. 16 h., and the solvent was removed under reduced pressure. 1H NMR of the crude 
reaction product showed the formation of two distinct species, identified by ESI-MS as: (i) 
[LFe3(F2ArPz)2(FPhPz)OFe(O)]2+ (7; m/z = 814.1) and (ii) [LFe3(F2ArPz)3OFe(F)]2+ (8; m/z = 
825.6); see Figure S37. Based on the relative integration of the peaks at 118.3 (7) and 107.3 ppm 
(8) in the crude reaction mixture – vs. a known 1:1 ratio of 7 and 8 – the relative ratios of 7 and 8 
are approximately 45:55 (7:8). Together with 7 and 8 a paramagnetic impurity is present and is of 
unknown identity. The species 7 and 8 were independently synthesized for identification, 
structural characterization, and confirmation of C–F bond activation with concomitant transfer of 
a fluorine anion (vide infra). 
 
[LFe3(F2ArPz)2(OFArPz)OFe][OTf]1 (6). In the glovebox, to a solution of 
[LFe3(F2ArPz)3OFe][OTf]2 (97.5 mg; 0.052 mmol) in CH2Cl2 (4.0 mL) was added a suspension 
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2-(1H-pyrazol-3-yl)-3-fluorophenolate (NaOFArPzH; 12.3 mg; 0.61 mmol) in CH2Cl2 (1.0 mL). 
The solution was stirred for ca. 24 h., during which the color changed from brown to red/brown. 
The solution was filtered over a bed of Celite (0.5 cm) in a glass pipette and the solvent removed 
under reduced pressure. The red/brown solid (94 mg) was crystallized from MeCN/Et2O to yield 
[LFe3(F2ArPz)2(OFArPz)OFe][OTf]1 as red/brown crystals. Yield 47 mg (51%). 1H NMR (300 
MHz, CD2Cl2) δ 128.6 (br), 126.0 (br), 122.7 (br), 91.2 (br), 86.0 (br), 75.7 (s), 75.2 (s), 74.3 (s), 
73.2 (s), 69.8 (s), 68.2 (s), 66.0 (br), 58.0 (s), 56.4 (s), 50.9 (s), 50.2 (s), 48.8 (s), 45.1 (s), 36.16 
(s), 35.7 (s), 34.6 (s), 30.7 (s), 30.0 (s), 24.5 (s), 24.1 (s), 18.5 (s), 14.7 (s), 13.3 (s), 13.3 (s), 12.6 
(s), 12.4 (s), 10.1 (s), 9.5 (s), 9.0 (s), -7.4 (br), -11.3 (br), -19.0 (s), -33.7 (br). 19F NMR (282 
MHz, CD2Cl2) δ -47.5, -58.5, -75.1, -78.7, -82.3, -98.8. UV-Vis (CH2Cl2) [ε (M-1 cm-1)]: 245 nm 
(12.21 × 104), 302 nm (2.41 × 104), 500 nm (7.32 × 103). Anal. calcd. (%) for 
C85H54F8Fe4N12O8S1: C 57.39, H 3.06, N 9.45; found: After several attempts, no suitable EA has 
been obtained yet.  
 
[LFe3(F2ArPz)2(OFArPz)OFe][OTf]2 (7) Method A. In the glovebox, to a rapidly stirred 
solution of [LFe3(F2ArPz)2(OFArPz)OFe][OTf]1 (90 mg, 0.05 mmol) in CH2Cl2 (5.0 mL) was 
added silver triflate (AgOTf; 12.4 mg, 0.05 mmol) as a suspension in CH2Cl2 (1.0 mL). The 
solution was stirred for 2 h., during which the color changed from red/brown to green/black. The 
solution was filtered over a bed of Celite (0.5 cm) in a glass pipette, and the solvent was removed 
under reduced pressure to yield a crude black solid (89 mg). The black solid (70 mg) was 
recrystallized from MeCN/Et2O to [LFe3(F2ArPz)2(OFArPz)OFe][OTf]2 as black crystals. Yield 
37.4 mg (53%). 1H NMR (300 MHz, CD2Cl2) δ 154.1 (br), 145.3 (br), 131.1 (br), 117.4 (br), 
106.7 (br), 91.6 (br), 84.6 (s), 82.8 (s), 82.3 (s), 77.5 (s), 71.2 (s), 70.6 (s), 68.2 (s), 67.0 (s), 64.9 
(s), 61.5 (s), 56.6 (s), 47.9 (s), 40.4 (s), 38.1 (s), 35.5 (s), 30.5 (s), 16.7 (s), 15.5 (s), 15.4 (s), 15.2 
(s), 14.1 (s), 12.8 (s), 12.4 (s), 11.4 (s), 10.3 (s), 9.9 (s), -1.4 (br), -4.4 (br), -9.1 (br) , -17.4 (br), -
22.6 (s). 19F NMR (282 MHz, CD2Cl2) δ -46.9, -66.5, -67.3, -78.0, -79.3, -103.6, -110.8, -111.5. 
UV-Vis (CH2Cl2) [ε (M-1 cm-1)]: 242 nm (10.73 × 104), 345 nm (1.22 × 104), 430 nm (8.35 × 103), 
582 nm (4.58 × 103). Anal. calcd. (%) for C86H54F11Fe4N12O11S2: C 53.58, H 2.82, N 8.72; found: 
C 53.29, H 3.11, N 8.56. 
 
[LFe3(F2ArPz)2(OFArPz)OFe][OTf]2 (7) Method B. In the glovebox, to a stirring solution of 
[LFe3(F2ArPz)3OFe][OTf]2 (203.1 mg, 0.1 mmol) in DCM (8.0 mL) was added a solution of 
tetrabutylammoniun periodate (nBu4NIO4; 46.2 mg, 0.1 mmol) in DCM (1.0 mL). The yellow 
brown solution turned green/black immediately and after 30 minutes the solvents were removed 
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under reduced pressure to yield a crude black solid (217 mg). The 1H NMR of the crude solid is 
similar to that of [LFe3(F2ArPz)2(OFArPz)OFe][OTf]2, although a small paramagnetic impurity is 
present (Figure S30). No [LFe3(F2ArPz)3OFe(F)][OTf]2 (8) was detected by 1H NMR, most likely 
due to the near immediate conversion of 5 to 7.  
 
[LFe3(F2ArPz)3OFe(F)][OTf]2 (8). In the glovebox, to a solution of [LFe3(F2ArPz)3OFe][OTf]2 
(380.0 mg; 0.2 mmol) in acetonitrile (10 mL) was added a solution of xenon difluoride (XeF2; 
40.0 mg.; 0.23 mmol) in acetonitrile (2 mL). The solution darkened immediately to dark brown 
and was stirred for an additional 2h. The volatiles were removed under reduced pressure to give 
give [LFe3(F2ArPz)3OFe(F)][OTf]2 as crude brown solid (374 mg > 95% conversion by 1H 
NMR). Crystallization from DCM/Et2O only gave a few poor crystals suitable for X-ray analyses.  
Crystallization of the crude brown solid (4 x 30 mg) from CH2Cl2/C6H6 gave brown crystals. 
Yield 68.9 mg (57%). 1H NMR (300 MHz, CD2Cl2) δ 145.8 (br), 107.4 (br), 85.6 (s), 67.3 (s), 
64.4 (s), 44.7 (s), 16.0 (s), 12.8 (s), 11.6 (s), 11.0 (s), 10.1 (s), -1.6 (s), -10.7 (s). 19F NMR (282 
MHz, CD2Cl2) δ -72.0, -77.0, -80.6. UV-Vis (CH2Cl2) [ε (M-1 cm-1)]: 243 nm (9.57 × 104), 357 
nm (9.34 × 103), 437 nm (6.88 × 103). Anal. calcd. (%) for C86H54F13Fe4N12O10S2: C 52.97, H 
2.79, N 8.62; found: After several attempts, no suitable EA has been obtained yet.  
 
Reaction of PhIO with Sodium 3-phenylpyrazolate. In the glovebox, to a suspension of 
iodosobenzene (PhIO; 22.5 mg; 0.1 mmol) in 2 mL THF was added a solution of sodium 3-
phenylpyrazolate (NaPhPz; 16.7 mg; 0.1 mmol) in 3 mL THF. The resulting suspension was 
stirred for 16 h, and remained a suspension throughout. The mixture was divided into two 
portions (2 × 2.5 mL). The first 2.5 mL fraction was filtered and the solvent was removed under 
reduced pressure to yield 10.2 mg of a crude solid. 1H NMR (in CD3CN + 5 µL CH2Cl2 as 
internal standard) of the crude solid did not indicate hydroxylation of the pyrazole ligand (Figure 
S30). Based on the internal standard the yield, was 5.0 mg (60%). From the second 2.5 mL 
fraction, the solvent was removed under reduced pressure to yield 21.0 mg of crude solid. Outside 
the glovebox, to the solid was added 1.0 mL MeOH, 1.0 mL THF, 1.0 mL H2O, 0.5 mL NH4Cl 
(sat.), and subsequently solubilized. The solution was filtered over alumina and analyzed by gas 
chromatography mass spectroscopy (GC-MS). GC-MS did not show any peak of the pyrazole 
ligand.  
 
Reaction of PhIO with Sodium 3-(2,6-difluorophenyl)pyrazolate. In the glovebox, to a 
suspension of iodosobenzene (PhIO; 22.2 mg; 0.1 mmol) in 2 mL THF was added a solution of 
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sodium 3-(2,6-difluorophenyl)pyrazolate (NaF2ArPz; 20.2 mg; 0.1 mmol) in 3 mL THF. The 
resulting suspension was stirred for 16 h, and remained a suspension throughout. The mixture was 
divided into two portions (2 × 2.5 mL). The first 2.5 mL fraction was filtered and the solvent was 
removed under reduced pressure to yield 9.9 mg of a crude solid. 1H NMR (in CD3CN + 5 µL 
CH2Cl2 as internal standard) of the crude solid did not indicate hydroxylation of the pyrazole 
ligand (Figure S31). Based on the internal standard the yield, was 9.0 mg (90%). After NMR 
analysis, outside the glovebox, to the NMR sample was added 1.0 mL H2O, 0.2 mL HCl (conc.), 
0.2 mL NaOH (9M). The solution was extracted with CH2Cl2 (2 × 1.0 mL), and the organic 
fraction was filtered over alumina and analyzed by gas chromatography mass spectroscopy (GC-
MS). GC-MS did not show any peak of the pyrazole ligand.  
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Figure S1. 1H NMR spectrum (400 MHz) of 1-(2-fluoro-6-methoxyphenyl)ethan-1-ol in CDCl3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2. 13C NMR spectrum (400 MHz) of 1-(2-fluoro-6-methoxyphenyl)ethan-1-ol in CDCl3. 
	   S17	  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S3. 1H NMR spectrum (400 MHz) of 2-fluoro-6-methoxyacetophenone in CDCl3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S4. 13C NMR spectrum (400 MHz) of 2-fluoro-6-methoxyacetophenone in CDCl3. 
 
	   S18	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S5. 1H NMR spectrum (400 MHz) of 3-(2-fluoro-6-methoxyphenyl)-1H-pyrazole in 
CDCl3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S6. 13C NMR spectrum (400 MHz) of 3-(2-fluoro-6-methoxyphenyl)-1H-pyrazole in 
CDCl3. 
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Figure S7. 1H NMR spectrum (400 MHz) of 3-(2-fluoro-6-hydroxyphenyl)-1H-pyrazole in 
CD3CN. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S8. 13C NMR spectrum (400 MHz) of 3-(2-fluoro-6-hydroxyphenyl)-1H-pyrazole in 
CD3CN. 
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Figure S9. 1H NMR spectrum (400 MHz) of sodium 2-(1H-pyrazol-3-yl)-3-fluorophenolate in 
CD3CN. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S10. 13C NMR spectrum (400 MHz) of sodium 2-(1H-pyrazol-3-yl)-3-fluorophenolate in 
CD3CN. 
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Figure S11. 1H NMR spectrum (400 MHz) of 3-(2,6-difluorophenyl)-1H-pyrazole in CD3CN. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S12. 13C NMR spectrum (400 MHz) of 3-(2,6-difluorophenyl)-1H-pyrazole in CD3CN. 
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Figure S13. 1H NMR spectrum (400 MHz) of sodium 3-(2,6-difluorophenyl)pyrazolate in 
CD3CN. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S14. 13C NMR spectrum (400 MHz) of sodium 3-(2,6-difluorophenyl)pyrazolate in 
CD3CN. 
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Figure S15. 1H NMR spectrum (400 MHz) of sodium 2-(1H-pyrazol-3-yl)phenolate in CD3CN. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S16. 13C NMR spectrum (400 MHz) of sodium 2-(1H-pyrazol-3-yl)phenolate in CD3CN 
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Figure S17. 1H NMR spectrum (300 MHz) of [LFe3(PhPz)2(OArPz)OFe][OTf] (3) in CD2Cl2 
from method A. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S18. 1H NMR spectrum (300 MHz) of [LFe3(PhPz)2(OArPz)OFe][OTf] (3) in CD2Cl2 
from method B. 
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Figure S19. 1H NMR spectrum (300 MHz) of [LFe3(PhPz)2(OArPz)OFe][OTf]2 (2) in CD2Cl2 
from method A. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S20. 1H NMR spectrum (300 MHz) of [LFe3(PhPz)2(OArPz)OFe][OTf]2 (2) in CD2Cl2 
from method B. 
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Figure S21. 1H NMR spectrum (300 MHz) of [LFe3(PhPz)2(OArPz)OFe][OTf]2 (2) in CD2Cl2 
from method C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S22. Stacked 1H NMR spectrum (300 MHz) of [LFe3(PhPz)2(OArPz)OFe][OTf]2 (2) from 
method D (red), and with [LFe3(PhPz)2(OArPz)OFe][OTf]2 (2) from method A (green) in 
CD2Cl2. 
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Figure S23. Stacked 1H NMR spectrum (300 MHz) of [LFe3(PhPz)2(OArPz)OFe][OTf]2 (2) in 
CD2Cl2 from method A–C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S24. 1H NMR spectrum (300 MHz) of [LFe3(F2ArPz)3OFe][OTf] (4) in CD2Cl2. 
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Figure S25. 1H NMR spectrum (300 MHz) of [LFe3(F2arPz)3OFe][OTf]2 (5) in CD2Cl2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S26. Crude 1H NMR spectrum (300 MHz) of the reaction of [LFe3(F2ArPz)3OFe][OTf]2 
(5) with PhIO for 16 h. in CD2Cl2. 
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Figure S27. Stacked 1H NMR spectrum (300 MHz) of [LFe3(F2ArPz)3OFe][OTf]2 (5) with PhIO 
(red), [LFe3(F2ArPz)2(OFArPz)OFe][OTf]2 (7; green), and [LFe3(F2ArPz)3OFe(F)][OTf]2 (8); 
blue) in CD2Cl2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S28. 1H NMR spectrum (300 MHz) of [LFe3(F2ArPz)2(OFArPz)OFe][OTf] (6) in CD2Cl2. 
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Figure S29. 1H NMR spectrum (300 MHz) of [LFe3(F2ArPz)2(OFArPz)OFe][OTf]2 (7) in CD2Cl2 
from method A. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S30. Stacked 1H NMR spectrum (300 MHz) of [LFe3(F2ArPz)2(OFArPz)OFe][OTf]2 (7) 
from method B (red), and with [LFe3(F2ArPz)2(OFArPz)OFe][OTf]2 (7) from method A (green) 
in CD2Cl2. 
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Figure S31. 1H NMR spectrum (300 MHz) of [LFe3(F2ArPz)3OFe(F)][OTf]2 (8) in CD2Cl2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S32. 1H NMR spectrum (300 MHz) of NaPhPz in CD3CN (top), and that of the crude 
reaction mixture upon reacting NaPhPz with PhIO (bottom). 
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Figure S33. 1H NMR spectrum (300 MHz) of NaF2ArPz in CD3CN (top), and that of the crude 
reaction mixture upon reacting NaF2ArPz with PhIO (bottom). 
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Figure S34. Electrospray Ionization Mass spectrum (ESI-MS) of (A) the crude reaction mixture 
upon treatment of 2 with PhIO and (B) the corresponding isotope distribution pattern. 
 
 
A) 
B) 
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Figure S35. Electrospray Ionization Mass spectrum (ESI-MS) of (A) the crude reaction mixture 
upon treatment of 2 with PhIO and (B) the corresponding isotope distribution pattern. 	  	  
A) 
B) 
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Figure S36. Electrospray Ionization Mass spectrum (ESI-MS) of (A) [LFe3(F2ArPz)3OFe][OTf]2 
(5) and (B) the corresponding isotope distribution pattern.  	  	  
A) 
B) 
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Figure S37. Electrospray Ionization Mass spectrum (ESI-MS) of (A) the crude reaction mixture 
upon treatment of 5 with PhIO and (B) the corresponding isotope distribution pattern. 
 
A) 
B) 
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Mössbauer simulation details for compounds 2, 3, and 5-8. All spectra were simulated by four 
pairs of symmetric quadrupole doublets with equal populations and Lorentzian lineshapes, and 
refined to a minimum by the method of least squares optimization (a total of 13 fitting parameters 
per spectrum). For all spectra, the observed resonances spanned the region from -1–3 mm s-1. Any 
resonances appearing above 2 mm s-1 indicate the presence of high spin Fe(II) centers and must 
correspond to species with isomer shifts ~1 mm s-1, given the range of observed resonances. 
Details regarding the fitting of individual spectra are given below. In short, the Mössbauer data 
were modeled to be consistent with our previously reported triiron-oxo/hydroxyl clusters,8 and 
our previously reported tetranuclear iron clusters.2 Overall, the observed Mössbauer parameters 
are in-line with those of other six-coordinate FeII/FeIII centers bearing N- and O-donor atoms.9-16 
 
Simulation details for [LFe3(PhPz)2(OPhPz)OFe][OTf]2 (2): The Mössbauer spectrum of 2 
features only five well-resolved resonances (opposed to the expected 8). A single symmetric 
Lorentzian appearing around 3 mm/s suggests a single high spin Fe(II) center, which is consistent 
with the crystallographic analysis of the basal Fe3 core (vide infra). The residual signals are 
centered on 0.5 mm/s, and within the range expected for high spin Fe(III) ions. An initial 
simulation was performed using only three quadrupole doublets to fit the five observed features 
(Fig. S38A). After optimization, the refined parameters were consistent with two high spin Fe(III) 
and one high spin Fe(II) in a 2:1:1 ratio. Thus, to obtain a final simulation, the most intense 
Fe(III) signal was split into two distinct resonances, and all species were refined with equal 
populations (Fig. S38B).  
 
 
 
 
 
 
 
 
 
 
Figure S38. (A) Initial simulation of 2 (black dots) fit to three quadrupole doublets. Simulation is 
shown in grey, with parameters: (i) δ = 1.17 mm/s, ⏐ΔEQ⏐= 2.96 mm/s (23%, solid blue trace); 
(ii) δ = 0.38 mm/s, ⏐ΔEQ⏐= 1.72 mm/s (24%, purple red trace); and (iii) δ = 0.46 mm/s, ⏐ΔEQ⏐= 
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0.79 mm/s (59%, solid orange trace). Residuals shown in black (SSE = 1.42). (B) Final 
simulation of 2 (black dots) fit to four quadrupole doublets. Simulation is shown in grey, with 
parameters: (i) δ = 1.17 mm/s, ⏐ΔEQ⏐= 2.96 mm/s (26%, solid blue trace); (ii) δ = 0.40 mm/s, 
⏐ΔEQ⏐= 1.72 mm/s (26%, solid purple trace); (iii) δ = 0.47 mm/s, ⏐ΔEQ⏐= 0.99 mm/s (26%, 
dashed orange trace); and (iv) δ = 0.47 mm/s, ⏐ΔEQ⏐= 0.56 mm/s (26%, solid orange trace). 
Residuals shown in black (SSE = 1.27). 
 
Simulation details for [LFe3(PhPz)2(OPhPz)OFe][OTf] (3): The Mössbauer spectrum of 3 
exhibits five well-resolved resonances. As with 2, the Lorentzian appearing near 3 mm/s suggests 
the presence of high spin ferrous ions, and the asymmetric line shape further indicates at least two 
such Fe(II) centers, which is consistent with the crystallographic analysis of the basal Fe3 core 
(vide infra). Based on the positions and intensities of the nearly overlapping Fe(II) quadrupole 
doublets, these features can be straightforwardly modeled and subtracted to clarify further 
analysis (Fig. S39A–B). After subtraction, the residual signal reveals four Lorentzians of 
approximately equal area, and thus a priori there are three reasonable simulations. As one 
simulation leads to a quadrupole doublet with a negative isomer shift, this simulation was rejected 
(not shown). Of the remaining two simulations of the Fe(III) metal centers, the one shown in 
Figure S39B (orange and purple traces) provides a superior fit to the data, and also reveals 
Mössbauer parameters typical of high spin Fe(III) centers. Moreover, the observed isomer shifts 
match well with those found for the Fe(III) centers of 2 (vide supra). Thus the final simulation 
shown in Figure S39B is preferred to that shown in Figure 39A. Consequently, the final 
simulation shown in Figure S39D is preferred to that shown in C. 
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Figure S39. (A) Simulation of 3 (black dots) after subtraction of high spin Fe(II) components. 
Simulation is shown in grey, with parameters: (i) δ = 0.76 mm/s, ⏐ΔEQ⏐= 1.26 mm/s (solid 
orange trace); and (ii) δ = 0.22 mm/s, ⏐ΔEQ⏐= 1.36 mm/s (solid purple trace). (B) Simulation of 
3 (black dots) after subtraction of high spin Fe(II) components. Simulation is shown in grey, with 
parameters: (i) δ = 0.52 mm/s, ⏐ΔEQ⏐= 0.77 mm/s (solid orange trace); and (ii) δ = 0.46 mm/s, 
⏐ΔEQ⏐= 1.84 mm/s (solid purple trace). (C) Simulation of 3 (black dots) fit to four quadrupole 
doublets. Simulation is shown in grey, with parameters: (i) δ = 1.08 mm/s, ⏐ΔEQ⏐= 3.24 mm/s 
(solid blue trace); (ii) δ = 1.06 mm/s, ⏐ΔEQ⏐= 2.95 mm/s (dashed blue trace); (iii) δ = 0.76 mm/s, 
⏐ΔEQ⏐= 1.26 mm/s (solid orange trace); and (iv) δ = 0.22 mm/s, ⏐ΔEQ⏐= 1.36 mm/s (solid 
purple trace). (D) Simulation of 3 (black dots) fit to four quadrupole doublets. Simulation is 
shown in grey, with parameters: (i) δ = 1.08 mm/s, ⏐ΔEQ⏐= 3.24 mm/s (solid blue trace); and (ii) 
δ = 1.06 mm/s, ⏐ΔEQ⏐= 2.95 mm/s (dashed blue trace) (iii) δ = 0.52 mm/s, ⏐ΔEQ⏐= 0.77 mm/s 
(dashed orange trace); (iv)  δ = 0.46 mm/s, ⏐ΔEQ⏐= 1.84 mm/s (solid purple trace). Residuals are 
shown in black (SSE = 4.57 for A and = 3.61 for B). 
 
Simulation details for [LFe3(F2ArPz)3OFe][OTf]2 (5): The Mössbauer spectrum of 5 exhibits 
five resolved features, with the Lorentzians appearing near 3 mm s-1 indicating the presence of 
two high spin ferrous ions. The spectrum was preliminarily simulated with a set of three 
quadrupole doublets to fit the five features, resulting in two reasonable simulations (Fig. S40A–
B). Both simulations result in parameters consistent with two high spin Fe(II) centers and a high 
spin Fe(III) center in a 1:1:2 ratio. The spectrum shown in Figure S40B furnishes a slightly 
superior simulation, and has parameters for the Fe(II) ions that are self-consistent with those 
observed for the other species reported here, and thus the final simulation was performed by 
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splitting the Fe(III) resonance in this spectrum in two and refining all species with equal 
populations (Fig. S40C).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S40. (A) Initial simulation of 5 (black dots) with three quadrupole doublets. Simulation is 
shown in grey, with parameters: (i) δ = 1.20 mm/s, ⏐ΔEQ⏐= 3.08 mm/s (solid blue trace, 35%); 
(ii) δ = 0.85 mm/s, ⏐ΔEQ⏐= 2.85 mm/s (solid green trace, 17%); and (iii) δ = 0.46 mm/s, ⏐ΔEQ⏐= 
0.74 mm/s (solid orange trace, 58%). (B) Initial simulation of 5 (black dots) with three 
quadrupole doublets. Simulation is shown in grey, with parameters: (i) δ = 1.12 mm/s, ⏐ΔEQ⏐= 
3.32 mm/s (solid blue trace, 25%); (ii) δ = 1.03 mm/s, ⏐ΔEQ⏐= 2.60 mm/s (solid green trace, 
28%); and (iii) δ = 0.46 mm/s, ⏐ΔEQ⏐= 0.74 mm/s (solid orange trace, 58%). (C) Final 
simulation of 5 (black dots) with four quadrupole doublets. Simulation is shown in red, with 
parameters: (i) δ = 1.12 mm/s, ⏐ΔEQ⏐= 3.30 mm/s (solid blue trace); (ii) δ = 0.46 mm/s, ⏐ΔEQ⏐= 
0.94 mm/s (solid trace); (iii) δ = 0.45 mm/s, ⏐ΔEQ⏐= 0.54 mm/s (dashed orange trace); (iv) δ 
=1.00 mm/s, ⏐ΔEQ⏐= 2.60 mm/s solid green trace). Residuals are shown in grey (SSE = 1.75 for 
C). 
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Simulation details for [LFe3(F2ArPz)2(OFArPz)OFe][OTf] (6): The Mössbauer spectrum of 6 
exhibits five well-resolved resonances, and bears close resemblance to the spectrum of 3, 
demonstrating that the distal fluorine substitution has little impact on the local electronic structure 
about the Fe atoms. As with 3, an asymmetric feature around 3 mm s-1 results from two nearly 
overlapping quadrupole doublets attributable to high spin ferrous ions, which, after simulation, 
results in a residual signal with four Lorentzians of nearly equal areas. As with 3, of the two 
reasonable simulations (Fig. S41A–B), the one shown in Figure S41B provides a superior fit to 
the data, and also reveals Mössbauer parameters typical of high spin Fe(III) centers. Moreover, 
the observed isomer shifts agree well with those found for the Fe(III) centers of 3 (vide supra). 
Thus the simulation shown in Figure S41B is preferred to that shown in A. 
 
 
 
 
 
 
 
 
 
 
Figure S41. (A) Simulation of 6 (black dots) with four quadrupole doublets. Simulation is shown 
in grey, with parameters: (i) δ = 1.09 mm/s, ⏐ΔEQ⏐= 3.31 mm/s (solid blue trace); (ii) δ = 1.04 
mm/s, ⏐ΔEQ⏐= 2.92 mm/s (dashed blue trace); (iii) δ = 0.76 mm/s, ⏐ΔEQ⏐= 1.28 mm/s (solid 
orange trace); and (iv) δ = 0.21 mm/s, ⏐ΔEQ⏐= 1.42 mm/s (solid purple trace). Residuals shown 
in black (SSE = 1.58). (B) Simulation of 6 (black dots) with four quadrupole doublets. Simulation 
is shown in grey, with parameters: (i) δ = 1.08 mm/s, ⏐ΔEQ⏐= 3.32 mm/s (solid blue trace); (ii) δ 
= 1.06 mm/s, ⏐ΔEQ⏐= 2.88 mm/s (dashed blue trace); (iii) δ = 0.52 mm/s, ⏐ΔEQ⏐= 0.80 mm/s 
(solid orange trace); and (iv) δ = 0.45 mm/s, ⏐ΔEQ⏐= 1.90 mm/s (solid purple trace); Residuals 
are shown in grey (SSE = 1.58 for A and SSE = 1.47 for B). 
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Simulation details for [LFe3(F2ArPz)2(OFArPz)OFe][OTf]2 (7): The Mössbauer spectrum of 7 
exhibits only five well-resolved resonances. A single symmetric Lorentzian appearing around 3 
mm s-1 suggests a single high spin ferrous center, while the residual signal is centered on 0.5 mm 
s-1, within the range expected for high spin ferric ions. As with the spectrum of 2, an initial 
simulation was performed using only three quadrupole doublets to fit the five observed features 
(Fig. S42A). After optimization, the refined parameters were consistent with two high spin Fe(III) 
and one high spin Fe(II) in a 2:1:1 ratio. Thus, to obtain a final simulation, the most intense 
Fe(III) signal was split into two distinct resonances, and all species were refined with equal 
populations (Fig. S42B).  
 
 
 
 
 
 
 
 
 
 
Figure S42. (A) Initial simulation of 7 (black dots) fit to three quadrupole doublets. Simulation is 
shown in grey, with parameters: (i) δ = 1.15 mm/s, ⏐ΔEQ⏐= 2.95 mm/s (26%, solid blue trace); 
(ii) δ = 0.46 mm/s, ⏐ΔEQ⏐= 0.74 mm/s (58%, solid orange trace); and (iii) δ = 0.39 mm/s, 
⏐ΔEQ⏐= 1.62 mm/s (25%, solid purple trace). Residuals shown in black (SSE = 3.51). (B) Final 
simulation of 7 (black dots) fit to four quadrupole doublets. Simulation is shown in grey, with 
parameters: (i) δ = 1.15 mm/s, ⏐ΔEQ⏐= 2.96 mm/s (solid blue trace); (ii) δ = 0.47 mm/s, ⏐ΔEQ⏐= 
0.92 mm/s (solid orange trace); (iii) δ = 0.45 mm/s, ⏐ΔEQ⏐= 0.54 mm/s (dashed orange trace); 
and (iv) δ = 0.39 mm/s, ⏐ΔEQ⏐= 1.62 mm/s (solid purple trace);. Residuals shown in grey (SSE = 
2.73). 
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Simulation details for [LFe3(F2ArPz)3Fe(F)][OTf]2 (8): The Mössbauer spectrum of 8 
resembles closely those observed for both 2 and 7. A preliminary simulation with only three 
quadrupole doublets yields parameters consistent with two high spin Fe(III) and one high spin 
Fe(II) in a 2:1:1 ratio (Fig. S43A). Thus, to obtain a final simulation, the most intense Fe(III) 
signal was split into two distinct resonances, and all species were refined with equal populations 
(Fig. S43B).  
 
 
 
 
 
 
 
 
 
 
Figure S43. (A) Initial simulation of 8 (black dots) fit to three quadrupole doublets. Simulation is 
shown in grey, with parameters: (i) δ = 1.26 mm/s, ⏐ΔEQ⏐= 2.75 mm/s (21%, solid blue trace); 
(ii) δ = 0.46 mm/s, ⏐ΔEQ⏐= 0.75 mm/s (59%, solid orange trace); and (iii) δ = 0.32 mm/s, 
⏐ΔEQ⏐= 1.58 mm/s (29%, solid purple trace. Residuals shown in black (SSE = 4.10). (B) Final 
simulation of 8 (black dots) fit to four quadrupole doublets. Simulation is shown in grey, with 
parameters: (i) δ = 1.23 mm/s, ⏐ΔEQ⏐= 2.79 mm/s (solid blue trace); (ii) δ = 0.46 mm/s, ⏐ΔEQ⏐= 
0.92 mm/s (solid orange trace); (iii) δ = 0.46 mm/s, ⏐ΔEQ⏐= 0.58 mm/s (dashed orange trace); 
and (iv) δ = 0.34 mm/s, ⏐ΔEQ⏐= 1.61 mm/s (solid purple trace);. Residuals shown in grey (SSE = 
4.16 for B). 
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Figure S44. Crystal structure of [LFe3(PhPz)3(OArPz)OFe][OTf]2 (2). Ellipsoids are shown at the 
50% probability level. Hydrogen atoms, co-crystallized solvents molecules and outer sphere 
counter ions are not shown for clarity. 
 
Special Refinement Details for [LFe3(PhPz)2(OArPz)OFe][OTf]2. Compound 2 crystallizes in 
the monoclinic space group C2c with one molecule in the asymmetric unit together with two 
triflate counter ions and 1.3 molecules of co-crystallized diethyl ether, and 2.7 molecules of co-
crystallized acetonitrile. Each of the pyrazolate bridging ligands was modeled as a mixture of 2-
(1-pyrazol-3-yl)phenolate and 3-phenylpyrazolate. One of the triflate anions was disordered over 
two positions. One of the co-crystallized diethyl ether molecules is located near a crystallographic 
two-fold rotation axis. Additionally, there are two solvent accessible voids. One of which was 
modeled as a mixture of acetonitrile and diethyl ether. The other void was modeled as 2.5 
molecules of acetonitrile disordered over five crystallographically independent positions. All of 
the diethyl ether molecules were modeled with the help of distance restraints on the 1,2-distances 
(C-C, 1.54(1); O-C 1.43(1)) and 1,3-distances (O-C, 2.43(2); C-C, 2.34(2). 
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Figure S45. Crystal structure of [LFe3(PhPz)2(OArPz)OFe][OTf] (3). Ellipsoids are shown at the 
50% probability level. Hydrogen atoms, co-crystallized solvents and outer sphere counter ions are 
not shown for clarity. 
 
Special Refinement Details for [LFe3(PhPz)2(OArPz)OFe][OTf]. Compound 3 crystallizes in 
the monoclinic space group P21/c with one molecule in the asymmetric unit along with a single 
triflate counter ion, two molecules of co-crystallized diethyl ether and two molecules of co-
crystallized dichloromethane. One of the co-crystallized dichloromethane molecules has a 
rotational disorder and refined to occupancies of 36% and 64% respectively. The distances of 
both diethyl ether molecules were restrained 1.517 Å (C100–C101, C102–C103, C104–C105, and 
C106–C107), 1.411 Å (C101–O100, C102–O100, C105–O101, and C106–O101), 2.376 Å 
(C100–O100, C103–O100, C104–O101, and C107–O101), 2.743 Å (C101–C102 and C105–
C106), and 4.743 Å (C100–C103 and C104–C107). 
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Figure S46. Crystal structure of [LFe3(F2ArPz)3OFe][OTf]2 (5). Ellipsoids are shown at the 50% 
probability level. Hydrogen atoms, co-crystallized solvents molecules and outer sphere counter 
ions are not shown for clarity. 
 
Special Refinement Details for [LFe3(F2ArPz)3OFe][OTf]2. Compound 5 crystallizes in the 
monoclinic space group P21/c with one molecule in the asymmetric unit along with two triflate 
counter ions, one molecule of co-crystallized diethyl ether and 2.8 molecules of co-crystallized 
acetonitrile. Both of the triflate counter ions were disordered over two positions. The co-
crystallized diethyl ether and acetonitrile molecules are disordered over seven positions, two for 
diethyl ether and five for acetonitrile, in a large solvent accessible void. All acetonitrile molecules 
were refined with the help of distances restraints on the 1,2-distances (C-C, 1.16(1) and C-N, 
1.54(1)) and 1,3-distances (C-C 2.75(1)). 
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Figure S47. Crystal structure of [LFe3(F2ArPz)2(OFArPz)OFe][OTf]2 (7). Ellipsoids are shown at 
the 50% probability level. Hydrogen atoms, co-crystallized solvents molecules and outer sphere 
counter ions are not shown for clarity. 
 
Special Refinement Details for [LFe3(F2ArPz)2(OFArPz)OFe][OTf]2. Compound 7 
crystallizes in the monoclinic space group P21/n with one molecule in the asymmetric unit along 
with two triflate counter ions, one molecule of co-crystallized diethyl ether, one molecule of co-
crystallized water and 1.6 molecules of co-crystallized acetonitrile. One diethyl ether is 
disordered over two positions, with an additional occupational disorder with one acetonitrile. The 
disorder was satisfactorily modeled, and refined to occupancies of 60 % diethyl ether (O200 
through C207), 60% acetonitrile (N2 through C203), and 40% diethyl ether (O201 through 
C211). The distances in one of the diethyl ether molecules (O201 through C211) were restrained 
at 1.517 Å (C211–C210 and C209–C208), 1.411 Å (C210–O201 and C209–O201), 2.357 Å 
(C211–O201 and C208-O201), and 4.743 Å (C211–C208). All acetonitrile molecules were 
refined with the help of distances restraints on the 1,2-distances (C-C, 1.458 and C-N, 1.157) and 
1,3-distances (C-C 2.17). Enhanced rigid bond restraints were used on all solvent molecules.  
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Figure S48. Crystal structure of [LFe3(F2ArPz)3OFe(F)][OTf]2 (8). Ellipsoids are shown at the 
50% probability level. Hydrogen atoms, co-crystallized solvents molecules and outer sphere 
counter ions are not shown for clarity. 
 
Special Refinement Details for [LFe3(F2ArPz)3OFe(F)][OTf]2. Compound 8 crystallizes in the 
monoclinic space group P21/c with one molecule in the asymmetric unit along with two triflate 
counter ions, and one molecule of co-crystallized dichloromethane. Enhanced rigid bond 
restraints were used on the entire molecule. One of the triflates was disordered over two different 
positions refining to occupancies of 56% and 44% respectively. The co-crystallized 
dichloromethane molecule is disordered over five different positions and refined with 
occupancies of 8%, 10%, 10%, 25%, and 47%. All the disordered dichloromethane molecules are 
restrained to approximate isotropic behavior. 
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Table S1. Selected bond angles and distances for complexes 2, 3, and 5 and 7. 
 
Bond Distance (Å) Complex 
 2a 3 5 7 
Fe1–O1 2.054(4) 2.154(3) 2.154(3) 2.198(4) 
Fe2–O1 2.076(4) 2.119(3) 1.941(3) 1.978(4) 
Fe3–O1 1.999(4) 1.938(3) 1.919(3) 1.986(4) 
Fe4–O1 1.931(4) 1.867(3) 2.042(3) 1.914(4) 
Fe1–N13 2.090(5) 2.125(4) 2.116(4) 2.108(5) 
Fe2–N23 2.068(5) 2.135(4) 2.074(4) 2.076(5) 
Fe3–N33 2.064(3) 2.109(4) 2.095(4) 2.105(5) 
Fe4–N14 2.065(4) 2.083(4) 2.083(4) 2.063(5) 
Fe4–N24 2.049(5) 2.067(4) 2.113(4) 2.055(5) 
Fe4–N34 2.047(6) 2.066(4) 2.131(4) 2.071(5) 
Fe4-N40 - - 2.149(4) - 
N13–N14 1.373(7) 1.375(5) 1.387(5) 1.365(7) 
N23–N24 1.392(7) 1.404(6) 1.422(6) 1.374(7) 
N33–N34 1.381(7) 1.381(5) 1.404(6) 1.367(7) 
Fe4–O40 1.908(16) 1.911(3) - 1.867(5) 
     
Bond Angles (º)     
N14–Fe4–N24 121.4(2) 155.52(16) 117.22(15) 120.3(2) 
N24–Fe4–N34 120.5(2) 113.85(15) 124.21(16) 117.5(2) 
N34–Fe4–N14 117.8(2) 130.31(15) 117.30(16) 121.9(2) 
O1–Fe4–O40 156.8(12) 163.68(14) - - 
O1–Fe4–N40 - - 175.46(15) 171.4(2) 
aBond angles and distances are taken from with the disordered part of 2 with a chemical 
occupancy of 49.1%. 
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Table S2. Crystal and refinement data for complexes 2, 3, and 5. 
 	  
 Complex 2 Complex 3 Complex 5 
CCDC 1432377 1432376 1432378 
Empirical 
formula C96.5H80.05F6Fe4N14.7O12.34S2 C95H83Cl4F3Fe4N12O10S C97.52H75.28F12Fe4N15.76O11S2 
Formula 
weight (g/mol) 2044.49 2006.99 2159.38 
T (K) 100 100 100 
Radiation MoKα (λ = 0.71073) MoKα (λ = 0.71073) MoKα (λ = 0.71073) 
a (Å) 24.3192(13) 17.2200(5) 22.6768(14) 
b (Å) 30.6264(16) 26.3779(9) 17.6060(11) 
c (Å) 24.9005(14) 19.6922(6) 24.2443(14) 
α (deg) 90 90 90 
β (deg) 65.8456(17) 99.7240(10) 96.7988(18) 
γ (deg) 90 90 90 
V (Å3) 9224.85(17) 8816.2(5) 9611.4(10) 
Z 4 4 4 
Cryst. syst. Monoclinic Monoclinic Monoclinic 
Space group C2/c P21/c P21/c 
ρcalcg (cm3) 1.472 1.512 1.492 
2 σ range (deg) 4.46 to 50.046 4.47 to 53.468 3.28 to 54.984 
Crystal 
size/mm 0.20 × 0.19 × 0.09 0.22 × 0.19 × 0.10 0.35 × 028 × 0.26 
µ (mm-1) 0.745 0.865 0.727 
GOF 1.042 1.046 1.053 
R1, wR2 (I> 
2σ (I)) R1 = 0.0773, wR2 0.2051 
R1 = 0.0683, wR2 
0.1774 R1 = 0.0792, wR2 0.2235 
 
Table S3. Crystal and refinement data for complexes 7 and 8. 
 
 Complex 7 Complex 8 
CCDC 1432375 - 
Empirical 
formula C93.2H70.8F11Fe4N13.6O13S2 C87H53Cl2F13Fe4N12O10S2 
Formula 
weight (g/mol) 2085.75 2031.83 
T (K) 100 100 
Radiation CuKα (λ = 1.5478) CuKα (λ = 1.5478) 
a (Å) 14.9873(4) 22.4130(9) 
b (Å) 26.9656(7) 16.4854(8) 
c (Å) 22.7659(6) 24.6252(12) 
α (deg) 90 90 
β (deg) 100.818(2) 96.581(3) 
γ (deg) 90 90 
V (Å3) 9037.1(4) 9038.7(7) 
Z 4 4 
Cryst. syst. Monoclinic monoclinic 
Space group P21/n P21/c 
ρcalcg (cm3) 1.533 1.493 
2 σ range (deg) 5.134 to 149.08 3.968 to 141.102 
Crystal 
size/mm 0.15 × 0.1 × 0.04 0.2 × 0.1 × 0.1 
µ (mm-1) 6.292 6.809 
GOF 1.012 1.151 
R1, wR2 (I> 
2σ (I)) 
R1 = 0.0857, wR2 = 
0.2060 
R1 = 0.1492, wR2 = 
0.3675 
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Table S4. Mössbauer parameters for complexes 2,3, and 5-8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
# Complex Parameters 
  δ (mm/s) 
| Δ Eq | 
(mm/s) 
Γ (mm s-1) Relative area 
2 [LFe3(PhPz)2(OArPz)OFe][OTf]2 
0.47 
0.47 
1.17 
0.40 
0.99 
0.56 
2.96 
1.72 
0.39 
0.39 
0.52 
0.40 
0.26 
0.26 
0.26 
0.26 
3 [LFe3(PhPz)2(OArPz)OFe][OTf] 
0.52 
1.07 
1.09 
0.46 
0.77 
3.25 
2.89 
1.84 
0.40 
0.30 
0.59 
0.31 
0.27 
0.27 
0.27 
0.27 
5 [LFe3(F2ArPz)3OFe][OTf]2 
0.46 
0.45 
1.12 
1.00 
0.94 
0.54 
3.30 
2.60 
0.36 
0.37 
0.40 
0.53 
0.27 
0.27 
0.27 
0.27 
6 [LFe3(F2ArPz)2(OFArPz)OFe][OTf] 
0.52 
1.08 
1.06 
0.45 
0.80 
3.32 
2.88 
1.90 
0.38 
0.30 
0.55 
0.31 
0.27 
0.27 
0.27 
0.27 
7 LFe3(F2ArPz)2(OFArPz)OFe][OTf]2 
0.47 
0.45 
1.15 
0.39 
0.92 
0.54 
2.96 
1.62 
0.38 
0.37 
0.46 
0.34 
0.27 
0.27 
0.27 
0.27 
8 [LFe3(F2ArPz)3OFe(F)][OTf]2 
0.46 
0.46 
1.23 
0.34 
0.92 
0.58 
2.79 
1.61 
0.31 
0.33 
0.65 
0.37 
0.28 
0.28 
0.28 
0.28 
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